5 Effective Treatments for Removing Polyps from Nose
Nasal polyps are benign, soft growths that arise from the lining of the nasal passages and sinuses, and for many people they cause persistent congestion, reduced sense of smell, facial pressure, and recurrent infections. Understanding options for removing polyps from the nose matters because the condition—often linked to chronic rhinosinusitis, asthma, and aspirin-exacerbated respiratory disease—tends to recur when the underlying inflammation is not controlled. This article outlines five effective treatment approaches, explaining how each works, typical outcomes, and when a specialist referral is appropriate. The aim is to present balanced, evidence-based information that helps patients and caregivers discuss realistic options with an ear, nose, and throat (ENT) specialist or their primary care provider without replacing personalized medical advice.
How effective are corticosteroid nasal sprays for nasal polyps?
Topical intranasal corticosteroids are the cornerstone of initial nasal polyp management and are often recommended as first-line therapy because they reduce local inflammation, shrink polyp tissue, and improve symptoms such as congestion and loss of smell. Corticosteroid sprays (or steroid nasal drops/irrigations in selected cases) work by decreasing eosinophilic inflammation and mucosal swelling and are safe when used as prescribed over months. Regular use can delay or reduce the need for surgery, but sprays may take weeks to produce maximal benefit, and adherence to daily application is essential. Side effects are generally mild—nasal dryness, crusting, or minor nosebleeds—while systemic steroid exposure is minimal compared with oral steroids. Discuss proper technique and fit with your clinician to maximize delivery to the sinuses.
When are short courses of oral corticosteroids recommended and what are the risks?
Oral corticosteroids are used as a short-term option to rapidly reduce large or symptomatic polyps, particularly when breathing is seriously compromised or when symptoms fail to respond to topical therapy. A typical course lasts several days to a few weeks and often produces dramatic symptom relief, shrinking polyps rapidly and improving airway patency and sense of smell. However, systemic steroids have well-known risks—elevated blood sugar, mood changes, blood pressure effects, bone density loss with repeated courses, and increased infection risk—so clinicians reserve them for acute control or as a bridge to longer-term strategies. Careful monitoring and limiting the total exposure to systemic steroids are important, and clinicians often combine a single short course with maintenance topical therapy or other interventions to reduce recurrence.
What does endoscopic sinus surgery (polypectomy) involve and who should consider it?
Endoscopic sinus surgery (ESS), including surgical polypectomy with mucosal preservation, is the primary procedural option when medical therapy fails to control symptoms or when polyps obstruct sinus drainage and cause recurrent infections. Performed through the nostrils using an endoscope and specialized instruments, ESS removes obstructing polyp tissue, opens sinus ostia, and allows topical medications to reach deeper sinus cavities more effectively. Recovery is typically outpatient with several days of congestion and crusting and several weeks of progressive improvement. Surgery reduces polyp burden and improves quality of life, but it does not cure the underlying inflammatory disease—many patients require ongoing topical therapy and, in some cases, repeat procedures. Below is a concise comparison of common treatment options to help weigh benefits, recovery, and recurrence risk.
| Treatment | Primary benefit | Typical recovery | Recurrence risk |
|---|---|---|---|
| Intranasal corticosteroids | Reduces inflammation, non-invasive | No downtime | Moderate—best with long-term use |
| Oral corticosteroids | Rapid shrinkage of polyps | Minimal downtime; short courses | High if used alone repeatedly |
| Endoscopic sinus surgery | Removes bulk, restores drainage | Days to weeks | Moderate to high without ongoing medical therapy |
| Biologic therapies | Targets underlying immune pathways | No surgical downtime | Can substantially reduce recurrence in responders |
| Saline irrigations / adjuncts | Improves mucociliary clearance and medication delivery | No downtime | Adjunctive—helps maintain surgical or medical gains |
Can biologic therapies shrink nasal polyps and who benefits?
Biologic agents that target specific immune pathways—such as IL-4/IL-13, IgE, or IL-5—have emerged as an important option for people with severe chronic rhinosinusitis with nasal polyps (CRSwNP) who do not respond adequately to standard medical therapy or who have contraindications to surgery. In clinical studies, these biologics can reduce polyp size, improve nasal congestion and smell, and decrease the need for systemic steroids and revision surgery. Treatment is typically administered by injection on a scheduled basis and is tailored to patients with markers of type 2 inflammation; access and insurance coverage vary by region and indication. Because biologics are relatively new and costly, ENT specialists and allergists usually reserve them for selected patients after thorough evaluation of benefits, risks, and long-term management plans.
What non-surgical maintenance strategies reduce polyp recurrence?
Long-term management focuses on controlling the chronic inflammation that drives polyp formation. Regular saline irrigations, steroid nasal sprays or steroid irrigations, allergy management, and smoking cessation all contribute to better symptom control and lower recurrence risk. For patients with aspirin-exacerbated respiratory disease (AERD), aspirin desensitization under specialist supervision can reduce polyp regrowth and improve asthma control. Maintaining follow-up with an ENT or allergy specialist is key—periodic nasal endoscopy, symptom tracking, and stepwise adjustments to therapy help detect recurrence early and avoid repeated high-dose systemic steroid exposure. Patient education on proper nasal spray technique and adherence to daily maintenance therapies significantly improves long-term outcomes.
How should patients choose the right treatment and what to expect afterward
Choosing among these five options—topical corticosteroids, short oral steroid courses, endoscopic sinus surgery, biologic therapies, and maintenance strategies—depends on symptom severity, prior responses to treatment, comorbid conditions (like asthma or AERD), and patient preferences. A stepped-care approach is common: begin with topical therapy, reserve oral steroids for flares, consider surgery when obstruction or infection persists, and evaluate biologic therapy for refractory or severe disease. After any intervention, expect ongoing surveillance and a maintenance plan to minimize recurrence; combining procedural and medical treatments most reliably preserves symptom relief. Discuss risks, expected recovery, and costs with your ENT and, when appropriate, an allergy specialist to design an individualized plan that balances efficacy, safety, and quality of life.
Medical disclaimer: This article provides general information about treatment options for nasal polyps and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for recommendations tailored to your health history and current condition.
This text was generated using a large language model, and select text has been reviewed and moderated for purposes such as readability.
